MFS
NAGE

Mirabella Financial Services’s Niagen Bioscience NAGE Stock Holding History

Mirabella Financial Services’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-43,074
Closed -$190K – 1222
2026
Q1 		$190K Buy
43,074
+27,666
+180% +$149K 0.02% 799
2025
Q4 		$98K Buy
+15,408
New +$107K 0.01% 644

Other funds holding NAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Mirabella Financial Services's NAGE Position: Q2 2026 in Review

Mirabella Financial Services sold out of Niagen Bioscience (NAGE) in Q2 2026, closing a stake of 43,074 shares — an estimated $190K sold.

Mirabella Financial Services first reported a position in NAGE in Q4 2025 and held it in 2 quarters. The position peaked at $190K in Q1 2026. 139 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

  • Mirabella Financial Services reported no remaining Niagen Bioscience position as of Q2 2026 after selling out during the quarter.
  • Mirabella Financial Services sold 43,074 Niagen Bioscience shares in Q2 2026, an estimated $190K.
  • Mirabella Financial Services first reported a position in Niagen Bioscience in Q4 2025 and held it in 2 quarters.
  • Mirabella Financial Services's Niagen Bioscience position peaked at $190K in Q1 2026.
  • 139 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on Mirabella Financial Services's 13F filing for Q2 2026, filed 31 Jul 2026.